Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents

Anhelli Syrenicz1, Barbara Garanty-Bogacka, Małgorzata Syrenicz

  • 1Department of Endocrinology, Arterial Hypertension and Metabolic Diseases, Pomeranian Medical University, Szczecin, Poland. anhelli@asymed.ifg.pl

Insights

Low-grade systemic inflammation is linked to type 2 diabetes risk factors in obese youth. Inflammatory markers correlated with insulin resistance, HbA1c, lipids, and lifestyle factors, supporting links between inflammation and diabetes development.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Immunology

Background:

  • Growing evidence links low-grade systemic inflammation to type 2 diabetes pathogenesis.
  • Obesity is a significant risk factor for type 2 diabetes in children and adolescents.

Purpose of the Study:

  • To investigate the relationship between serum inflammatory markers and type 2 diabetes risk factors in obese children and adolescents.
  • To explore the role of inflammation in the development of type 2 diabetes in pediatric populations.

Main Methods:

  • Measured fasting levels of C-reactive protein (CRP), fibrinogen (FB), interleukin-6 (IL-6), interleukin 1-beta (IL-1beta), glucose, insulin, lipid profile, and white blood cell count (WBC) in 281 obese youth.
  • Assessed fasting glucose to insulin ratio (FGIR) as an insulin resistance index.
  • Utilized Pearson's correlation to analyze relationships between inflammatory markers and clinical parameters.

Main Results:

  • Inflammatory markers showed significant correlations with insulin resistance indices (e.g., FGIR).
  • Significant associations were found between inflammatory markers and HbA1c, lipid profile, hypertension, family history of type 2 diabetes, low physical fitness, and diet.
  • These findings highlight the link between systemic inflammation and multiple risk factors for type 2 diabetes.

Conclusions:

  • Serum inflammatory markers are significantly correlated with most factors implicated in type 2 diabetes development.
  • These results support the association between subclinical inflammation and type 2 diabetes risk in obese children and adolescents.
  • The study underscores the importance of addressing inflammation in the prevention and management of type 2 diabetes in youth.
Abstract

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...